Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Geron Corporation (GERN) Market Cap & Valuation Ratios

Geron Corporation (GERN) has a market cap of $719.6M, with earnings according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

GERNGeron CorporationFollow GERN — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
719.6M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
4 Nov, in 11 days

Peers

biotechnology · nearest by market cap · trailing 12 months
CompanyMkt cap, $BP/EEV/SalesEV/EBITDAFCF yieldRev. growthOp. marginROIC
GERN0.7——————-18%
FDMT0.8—4.8———-214%-56%
ARDX0.8—1.6—-2.3%+17%-8%-13%
ANNX0.8———————
SANA0.7——————-294%
OABI0.7—16.3—-2.7%+67%-126%-20%
DNA0.7—5.3——-52%-260%-78%
ACHV0.7———-7.4%———
PRME0.7—140.1——-18%——
AURA0.7——————-88%
DSGN0.6———-8.6%——-42%
Median of these 10—5.3—-5.0%-0.6%-170%-56%

.

Growth vs. price

each dot a company · hover or tap for values

Geron Corporation — questions

What is Geron Corporation's market cap?
$719.6M.

Every figure on this page comes from Geron Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.